Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Ma

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Zhonghua Xin Xue Guan Bing Za Zhi|September 22, 2020
[Progress and controversy in the management of atrial fibrillation]X Chen, Z X Jia, C S Ma
Zhonghua Xin Xue Guan Bing Za Zhi|January 14, 2025
[Research progression on arrhythmia-induced cardiomyopathy]X D Peng, S Zuo, C S Ma
Zhonghua Xin Xue Guan Bing Za Zhi|May 26, 2016
[Ablation of atrial fibrillation in patients with heart failure]J Cui, J Z Dong, C S Ma
Zhonghua Xin Xue Guan Bing Za Zhi|May 26, 2020
[Interpretation of the 2019 ESC guideline for the management of supraventricular tachycardia]J R Zhang, M M Li, C S Ma
Zhonghua Nei Ke Za Zhi|December 2, 2021
[The Chinese expert recommendations on the clinical use of dronedarone]Y H Sun, C S Ma, S L Wu
Zhonghua Xin Xue Guan Bing Za Zhi|September 25, 2019
[Development and prospect in atrial fibrillation prevention and management]X X Liu, S J Xia, C S Ma
Zhonghua Nei Ke Za Zhi|March 25, 2021
[Antiarrhythmic drug therapy for atrial fibrillation]J R Zhang, C Y Li, C S Ma
Zhonghua Xin Xue Guan Bing Za Zhi|March 11, 2021
[Rhythm control in patients with atrial fibrillation: how to optimize the application of antiarrhythmic drugs and catheter ablation]M Y Gao, X X Liu, C S Ma
Zhonghua Xin Xue Guan Bing Za Zhi|March 27, 2022
[Catheter ablation for persistent atrial fibrillation: approaches and technologies]T N Jiang, C H Sang, C S Ma
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 10, 2020
[Comparison of compliance and cost effectiveness between brand-name statins and generic statins]L He, X Du, W H Wang, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Zhonghua Xin Xue Guan Bing Za Zhi|September 22, 2020
[Progress and controversy in the management of atrial fibrillation]X Chen, Z X Jia, C S Ma
Zhonghua Xin Xue Guan Bing Za Zhi|January 14, 2025
[Research progression on arrhythmia-induced cardiomyopathy]X D Peng, S Zuo, C S Ma
Zhonghua Xin Xue Guan Bing Za Zhi|May 26, 2016
[Ablation of atrial fibrillation in patients with heart failure]J Cui, J Z Dong, C S Ma
Zhonghua Xin Xue Guan Bing Za Zhi|May 26, 2020
[Interpretation of the 2019 ESC guideline for the management of supraventricular tachycardia]J R Zhang, M M Li, C S Ma
Zhonghua Nei Ke Za Zhi|December 2, 2021
[The Chinese expert recommendations on the clinical use of dronedarone]Y H Sun, C S Ma, S L Wu
Zhonghua Xin Xue Guan Bing Za Zhi|September 25, 2019
[Development and prospect in atrial fibrillation prevention and management]X X Liu, S J Xia, C S Ma
Zhonghua Nei Ke Za Zhi|March 25, 2021
[Antiarrhythmic drug therapy for atrial fibrillation]J R Zhang, C Y Li, C S Ma
Zhonghua Xin Xue Guan Bing Za Zhi|March 11, 2021
[Rhythm control in patients with atrial fibrillation: how to optimize the application of antiarrhythmic drugs and catheter ablation]M Y Gao, X X Liu, C S Ma
Zhonghua Xin Xue Guan Bing Za Zhi|March 27, 2022
[Catheter ablation for persistent atrial fibrillation: approaches and technologies]T N Jiang, C H Sang, C S Ma
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 10, 2020
[Comparison of compliance and cost effectiveness between brand-name statins and generic statins]L He, X Du, W H Wang, et al.
Pageof 9